rosuvastatin mylan 5 mg
mylan ireland limited, Írsko - rosuvastatín - 31 - hypolipidaemica
rosuvastatin mylan 10 mg
mylan ireland limited, Írsko - rosuvastatín - 31 - hypolipidaemica
rosuvastatin mylan 20 mg
mylan ireland limited, Írsko - rosuvastatín - 31 - hypolipidaemica
rosuvastatin mylan 40 mg
mylan ireland limited, Írsko - rosuvastatín - 31 - hypolipidaemica
jakavi
novartis europharm limited - ruxolitinib (ako fosfát) - myeloproliferative disorders; polycythemia vera; graft vs host disease - antineoplastické činidlá - myelofibrosis (mf)jakavi is indicated for the treatment of disease related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. polycythaemia vera (pv)jakavi je indikovaný na liečbu dospelých pacientov s polycythaemia vera, ktorí sú odolné voči alebo netolerantné hydroxyurea. graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies (see section 5.
jodid draselný 65 hameln
hameln rds s. r. o., slovensko - jodid draselný - 19 - antidota, detoxicantia
zypsilan 20 mg
krka, d.d., novo mesto, slovinsko - ziprazidón - 68 - antipsychotica (neuroleptica)
zypsilan 40 mg
krka, d.d., novo mesto, slovinsko - ziprazidón - 68 - antipsychotica (neuroleptica)
zypsilan 60 mg
krka, d.d., novo mesto, slovinsko - ziprazidón - 68 - antipsychotica (neuroleptica)
zypsilan 80 mg
krka, d.d., novo mesto, slovinsko - ziprazidón - 68 - antipsychotica (neuroleptica)